Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)

Lin, N. U.; Guo, H.; Yap, J. T.; Mayer, I. A.; Falkson, C. I.; Hobday, T. J.; Dees, E. C.; Richardson, A. L.; Nanda, R.; Rimawi, M. F.; Ryabin, N.; Najita, J. S.; Barry, W. T.; Arteaga, C. L.; Wolff, A. C.; Krop, I. E.; Winer, E. P.; Van den Abbeele, A. D.

期刊名称Journal of Clinical Oncology
作者Lin, N. U.; Guo, H.; Yap, J. T.; Mayer, I. A.; Falkson, C. I.; Hobday, T. J.; Dees, E. C.; Richardson, A. L.; Nanda, R.; Rimawi, M. F.; Ryabin, N.; Najita, J. S.; Barry, W. T.; Arteaga, C. L.; Wolff, A. C.; Krop, I. E.; Winer, E. P.; Van den Abbeele, A. D.
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小332.37KB
发表时间2015-07-13
DOI10.1200/JCO.2014.60.0353

发现好书期刊，享受阅读乐趣

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)